Davidson Kempner Capital Management’s Boston Scientific BSX Stock Holding History

Davidson Kempner Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.97M	Buy	+63,250	New	+$5.06M	0.05%	146
2020 Q3	–	Sell	-200,000	Closed	-$7.02M	–	269
2020 Q2	$7.02M	Buy	+200,000	New	+$7.2M	0.17%	126
2017 Q1	–	Sell	-600,000	Closed	-$13M	–	167
2016 Q4	$13M	Buy	600,000 +100,000	+20%	+$2.18M	0.26%	82
2016 Q3	$11.9M	Buy	500,000 +125,000	+33%	+$2.98M	0.29%	71
2016 Q2	$8.76M	Buy	+375,000	New	+$8.11M	0.21%	89

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Davidson Kempner Capital Management's BSX Position: Q1 2026 in Review

Davidson Kempner Capital Management opened a new position in Boston Scientific (BSX) in Q1 2026: 63,250 shares worth $3.97M. The stake represents 0.05% of the portfolio and ranks #146 among its holdings. This is a return to the name: Davidson Kempner Capital Management previously reported a position in BSX as recently as Q2 2020.

Davidson Kempner Capital Management first reported a position in BSX in Q2 2016 and has held it in 5 quarters since. The position peaked at $13M in Q4 2016. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Davidson Kempner Capital Management held 63,250 shares of Boston Scientific worth $3.97M as of Q1 2026.
Boston Scientific was a new Davidson Kempner Capital Management position in Q1 2026.
Boston Scientific made up 0.05% of Davidson Kempner Capital Management's portfolio in Q1 2026, its #146 holding.
Davidson Kempner Capital Management first reported a position in Boston Scientific in Q2 2016 and has held it in 5 quarters since.
Davidson Kempner Capital Management's Boston Scientific position peaked at $13M in Q4 2016.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2026, filed 15 May 2026.